Dr Glenn C Douglas, MD | |
3601 The Vanderbilt Clinic, Nashville, TN 37232-8233 | |
(615) 936-2000 | |
Not Available |
Full Name | Dr Glenn C Douglas |
---|---|
Gender | Male |
Speciality | Rheumatology |
Experience | 26 Years |
Location | 3601 The Vanderbilt Clinic, Nashville, Tennessee |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1831121011 | NPI | - | NPPES |
4057044 | Other | BCBS | |
3880030 | Medicaid | TN | |
7603407 | Other | AETNA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RR0500X | Internal Medicine - Rheumatology | 37133 (Tennessee) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Vanderbilt University Medical Center | Nashville, TN | Hospital |
Marshall Medical Center | Lewisburg, TN | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Vanderbilt University Medical Center | 5092023416 | 2711 |
News Archive
Chemists have identified the complex chemical structure of the protein that stacks together to form fibrils in the brains of Parkinson's disease patients. Armed with this knowledge, researchers can identify specific targets for diagnosis and treatment.
Engineers funded by the National Institute of Biomedical Imaging and Bioengineering have developed a small monitoring device, worn on the skin, that detects alcohol levels in perspiration.
Cirrhosis related to non-alcoholic steatohepatitis (NASH) is associated with fewer complications and a lower mortality compared to cirrhosis from hepatitis C, despite NASH patients' greater risk of dying from cardiovascular events.
Cancer Research UK's commercialisation and development arm, Cancer Research Technology (CRT), today announced it has teamed up with biopharmaceutical business, AstraZeneca in a major, multi-project alliance, in which around 30 scientists will be focused on creating a stream of new anti-cancer drugs, it is announced today (Sunday).
› Verified 6 days ago
Entity Name | Vanderbilt University Medical Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1104202761 PECOS PAC ID: 5092023416 Enrollment ID: O20151006000369 |
News Archive
Chemists have identified the complex chemical structure of the protein that stacks together to form fibrils in the brains of Parkinson's disease patients. Armed with this knowledge, researchers can identify specific targets for diagnosis and treatment.
Engineers funded by the National Institute of Biomedical Imaging and Bioengineering have developed a small monitoring device, worn on the skin, that detects alcohol levels in perspiration.
Cirrhosis related to non-alcoholic steatohepatitis (NASH) is associated with fewer complications and a lower mortality compared to cirrhosis from hepatitis C, despite NASH patients' greater risk of dying from cardiovascular events.
Cancer Research UK's commercialisation and development arm, Cancer Research Technology (CRT), today announced it has teamed up with biopharmaceutical business, AstraZeneca in a major, multi-project alliance, in which around 30 scientists will be focused on creating a stream of new anti-cancer drugs, it is announced today (Sunday).
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Glenn C Douglas, MD 3841 Green Hills Village Dr Ste 200, Nashville, TN 37215-2691 Ph: () - | Dr Glenn C Douglas, MD 3601 The Vanderbilt Clinic, Nashville, TN 37232-8233 Ph: (615) 936-2000 |
News Archive
Chemists have identified the complex chemical structure of the protein that stacks together to form fibrils in the brains of Parkinson's disease patients. Armed with this knowledge, researchers can identify specific targets for diagnosis and treatment.
Engineers funded by the National Institute of Biomedical Imaging and Bioengineering have developed a small monitoring device, worn on the skin, that detects alcohol levels in perspiration.
Cirrhosis related to non-alcoholic steatohepatitis (NASH) is associated with fewer complications and a lower mortality compared to cirrhosis from hepatitis C, despite NASH patients' greater risk of dying from cardiovascular events.
Cancer Research UK's commercialisation and development arm, Cancer Research Technology (CRT), today announced it has teamed up with biopharmaceutical business, AstraZeneca in a major, multi-project alliance, in which around 30 scientists will be focused on creating a stream of new anti-cancer drugs, it is announced today (Sunday).
› Verified 6 days ago
Megan Desai, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 4220 Harding Pike, Nashville, TN 37205 Phone: 615-222-6726 Fax: 615-222-3702 | |
Harrison Klause, Rheumatology Medicare: Medicare Enrolled Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-322-3000 | |
John N Bowers, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 4230 Harding Pike Ste 500, Nashville, TN 37205 Phone: 629-255-2493 Fax: 629-255-4266 | |
Dr. Evan Zehr, MD Rheumatology Medicare: Medicare Enrolled Practice Location: 1161 21st Ave S, Nashville, TN 37232 Phone: 615-322-6943 | |
Spurthi N Bhatt, MD MPH Rheumatology Medicare: Medicare Enrolled Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-322-3000 | |
Mr. Robert M Johnson, MD Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 2410 Patterson St, Suite 106, Nashville, TN 37203 Phone: 615-340-4611 Fax: 615-340-4658 | |
Mr. John E Anderson, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2400 Patterson St, Suite 400, Nashville, TN 37203 Phone: 615-342-5900 Fax: 615-342-5912 |